UBS Maintains Neutral on Bruker, Raises Price Target to $45

Benzinga Newsdesk www.benzinga.com Positive 56.9%

Neg 0% Neu 0% Pos 56.9%

UBS analyst Dan Leonard maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target from $40 to $45.

Comments

No comments yet. Be the first!